Dr. Katrina A Guest, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 131, West Des Moines, IA 50266 Phone: 515-875-9550 Fax: 515-875-9551 |
Dr. Steven K Zorn, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4060 Westown Pkwy, West Des Moines, IA 50266 Phone: 515-225-0188 Fax: 515-225-0791 |
Dr. Angela Sue Collins, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 131, West Des Moines, IA 50266 Phone: 515-875-9550 Fax: 515-875-9551 |
James Christopher Mallen, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave Ste 131, West Des Moines, IA 50266 Phone: 515-875-9550 Fax: 515-875-9551 |
John Harwood Scott, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5950 University Ave Ste 131, West Des Moines, IA 50266 Phone: 515-875-9550 Fax: 515-875-9551 |
News Archive
New research led by Derya Unutmaz, MD associate professor, the Departments of Pathology, Medicine, and Microbiology at NYU School of Medicine and Mark Sundrud, PhD, of Tempero Pharmaceuticals, Inc., has identified a novel sensory pathway that modulates the potency of Th17 cell responses.
Olympus, a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, today announced the introduction of its improved user-friendly Endo Capsule Software version 1.02A, a customized and comprehensive system for examining high resolution small bowel images.
Metabolon, the leader in metabolomics, biomarker discovery and analysis, announced today the grant of US Patent No. 7,884,318 entitled "Systems, Methods, and Computer-Readable Medium for Determining Composition of Chemical Constituents in a Complex Mixture".
Children with autism have no unique pattern of abnormal results on endoscopy or other tests for gastrointestinal (GI) disorders, compared to non-autistic children with GI symptoms, reports a study in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
According to an advisory panel to the U.S. Food and Drug Administration, genetic tests sold directly to consumers that might help to predict health risks may need to be supplied through doctors. An official, Alberto Gutierrez, director of the FDA office that regulates diagnostic screening tools reported that the Molecular and Clinical Genetics Advisory Panel concluded two days of hearings on the increasingly popular tests and had come to this resolution.
› Verified 9 days ago